Patent · US Active

Assessment of pulmonary function in coronavirus patients

US12217432B2 · kind B2 · utility

0Cited by

0References

14Claims

0Family size

Assignee

University of Louisville Research Foundation, Inc. · US

Inventors

Ayman S. El-Baz · Louisville, US
Ahmed Shalaby · Louisville, US
Mohamed Elsharkawy · Louisville, US
Ahmed Sharafeldeen · Louisville, US
Ahmed Soliman · Louisville, US
Ali Mahmoud · Louisville, US
Harpal Sandhu · Louisville, US
Guruprasad A. Giridharan · Louisville, US

Key dates

Filing date	Mar 3, 2022
Grant date	Feb 4, 2025
Priority date	—
Expiry date	Apr 28, 2043

Classification

Technology area (CPC G)Physics
CPC primaryG16H50/30
WIPO fieldComputer technology
WIPO sectorElectrical engineering

Abstract

Assessment of pulmonary function in coronavirus patients includes use of a computer aided diagnostic (CAD) system to assess pulmonary function and risk of mortality in patients with coronavirus disease 2019 (COVID-19). The CAD system processes chest X-ray data from a patient, extracts imaging markers, and grades disease severity based at least in part on the extracted imaging markers, thereby distinguishing between higher risk and lower risk patients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.